Join
Live feed
·
INSIDERFilingvia Quantisnow
Klotho Neurosciences Inc. logo

Chief Executive Officer Sinkule Joseph disposed of 2,000,000 shares and was granted 537,180 shares, decreasing direct ownership by 25% to 4,446,700 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KLTO· Klotho Neurosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KLTO (Klotho Neurosciences Inc.) and more on Quantisnow.

Chief Executive Officer Sinkule Joseph disposed of 2,000,000 shares and was granted 537,180 shares, decreasing direct ownership by 25% to 4,446,700 units (SEC Form 4) | Quantisnow